ECP
MACK

Empyrean Capital Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Empyrean Capital Partners’s Portfolio MACK Stock Details MACK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-40,000
Closed -$152K – 65
2013
Q3 		$152K Buy
+40,000
New +$152K ﹤0.01% 38